COVID19 Oncology Impact Tracker
What are your risk mitigation plans?
Diagnosis rates are the earliest indicator to measure the potential impact to your business.
Here are 4 key reasons why Diaceutics market research is unmatched by any other agency:
Payers play a significant role in the pathway to diagnostic test access and reimbursement, and their insights into diagnostic test evaluation are key to optimizing adoption and removing access barriers.
Clinicians are the gatekeepers for testing, managing key elements of the diagnostic journey, as they are often the advocates for their patients, recommending and supporting new tests, to deliver the best possible treatment outcomes. It is vital to understand their role and perspectives when it comes to optimizing the commercialization of a diagnostic test.
One of Diaceutics’ most valuable services, our market research projects can be fully integrated into a comprehensive lab landscape, providing enhanced insights and a “story” to support the numbers uncovered through our rigorous landscape analyses.
Having the right equipment in the right laboratory is key to effective diagnostic integration. Technology is evolving rapidly, and capital equipment can be a real burden to some labs. Understanding the buying process of individual labs and the country specific nuances are key to ensuring the right equipment is available to support seamless testing.
Understanding physicians’ behavior when it comes to diagnostic testing is vital to optimizing the patient journey. Much can be learned from Diaceutics’ tester/non-tester differential research to help optimize physicians’ adoption of a specific test. These learnings help support diagnostic message development, medical science liaison tactics and overall brand strategy.